Focal therapy for localized prostate cancer with mpMRI/US fusion-guided radiofrequency ablation: Oncologic and functional outcomes
Main Authors: | W. Zhu, R. Yang, W. Wang, H. Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320334844 |
Similar Items
-
The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer
by: Xin Zhang, et al.
Published: (2022-10-01) -
mpMRI-US Fusion-Guided Targeted Cryotherapy in Patients with Primary Localized Prostate Cancer: A Prospective Analysis of Oncological and Functional Outcomes
by: Esaú Fernández-Pascual, et al.
Published: (2022-06-01) -
Analysis of the cause of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy
by: Fan Zhang, et al.
Published: (2022-05-01) -
Focal Irreversible Electroporation for Localized Prostate Cancer – Oncological and Safety Outcomes Using mpMRI and Transperineal Biopsy Follow-Up
by: Gielchinsky I, et al.
Published: (2023-01-01) -
Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?
by: Michael E. Rezaee, et al.
Published: (2020-09-01)